These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7852495)

  • 1. Modified glucagon test allowing simultaneous estimation of insulin secretion and insulin sensitivity: application to obesity, insulin-dependent diabetes mellitus, and noninsulin-dependent diabetes mellitus.
    Castillo MJ; Scheen AJ; Lefebvre PJ
    J Clin Endocrinol Metab; 1995 Feb; 80(2):393-9. PubMed ID: 7852495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.
    Ahrén B; Larsson H; Holst JJ
    J Clin Endocrinol Metab; 1997 Feb; 82(2):473-8. PubMed ID: 9024239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics.
    Pisu E; Lombardi A; De Benedictis D; Bozzo C; Chiara E; Baggiore C; Bruno A; Cravero L; Pagano G; Lenti G
    Acta Diabetol Lat; 1986; 23(3):215-25. PubMed ID: 3538736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
    Henry RR; Brechtel G; Griver K
    J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin and glucagon secretion are suppressed equally during both hyper- and euglycemia by moderate hyperinsulinemia in patients with diabetes mellitus.
    Murayama Y; Kawai K; Watanabe Y; Yoshikawa H; Yamashita K
    J Clin Endocrinol Metab; 1989 May; 68(5):925-31. PubMed ID: 2654170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
    Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
    N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of insulin secretion and insulin resistance in the clinical course of newly diagnosed diabetes mellitus in children].
    Szadkowska A; Pietrzak I; Markuszewski L; Bodalski J
    Med Wieku Rozwoj; 2005; 9(2):223-34. PubMed ID: 16085963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin resistance and insulin secretion in type II non-obese diabetics].
    Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
    Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent measures of insulin secretion and insulin sensitivity during the same test: the glucagon-insulin tolerance test.
    Dorkhan M; Tripathy D; Malm G; Asgharian H; Tuomi T; Groop L
    J Intern Med; 2008 Jul; 264(1):62-71. PubMed ID: 18298489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
    Christensen MB
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity.
    Mather KJ; Paradisi G; Leaming R; Hook G; Steinberg HO; Fineberg N; Hanley R; Baron AD
    Diabetes Metab Res Rev; 2002; 18(2):118-26. PubMed ID: 11994903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast.
    Clore JN; Post EP; Bailey DJ; Nestler JE; Blackard WG
    J Clin Endocrinol Metab; 1992 Mar; 74(3):660-6. PubMed ID: 1740502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
    Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight.
    Volk A; Renn W; Overkamp D; Mehnert B; Maerker E; Jacob S; Balletshofer B; Häring HU; Rett K
    Exp Clin Endocrinol Diabetes; 1999; 107(2):140-7. PubMed ID: 10320055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects.
    Salinari S; Bertuzzi A; Guidone C; Previti E; Rubino F; Mingrone G
    Ann Surg; 2013 Mar; 257(3):462-8. PubMed ID: 23388352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test.
    Menzel R; Pusch H; Ratzmann GW; Besch W; Förster F; Albrecht G; Ruhnke R
    Exp Clin Endocrinol; 1985 Feb; 85(1):81-8. PubMed ID: 3886415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.